Precision Antibody Powers the Future of Cancer Treatment as Key Sponsor of 15th World ADC San Diego
As a leader in antibody discovery, Precision Antibody joins forces with global innovators at the 15th World ADC San Diego to accelerate the development of breakthrough therapies in oncology.
- (1888PressRelease) November 08, 2024 - Baltimore, MD - Precision Antibody, a pioneering force in monoclonal antibody discovery and development, is excited to announce its sponsorship of the 15th World ADC San Diego, the premier global conference dedicated to advancing antibody-drug conjugate (ADC) therapeutics. The event, held from November 4-7, 2024, at the Town & Country San Diego, will bring together over 1,200 ADC experts, key opinion leaders, and biopharma professionals to discuss the latest innovations and developments in the field.
World ADC San Diego serves as the definitive forum for maximizing the therapeutic potential of ADCs, a class of targeted cancer therapies that have demonstrated tremendous promise in oncology. As ADCs continue to evolve, gaining momentum with landmark successes such as the tumor-agnostic approval of Enhertu and breakthrough results from Seagen and Astellas’ PADCEV, this conference is poised to shape the future of ADC drug development.
"Precision Antibody is excited to sponsor this prestigious event and contribute to the groundbreaking advancements in ADC therapeutics," said Dr. Jun Hayashi, President of Precision Antibody. "Our specialized expertise in antibody discovery and engineering aligns with the mission of World ADC San Diego to push the boundaries of what is possible in cancer treatment. We look forward to collaborating with other industry leaders and sharing our insights into how custom monoclonal antibodies can help accelerate ADC development." In addition, Dr. Jun Hayashi will be presenting a talk entitled Fully Human Monoclonal Antibody in 60 days that will illustrate the various services that Precision Antibody has developed for the ADC R&D community.
The Future of Antibody-Drug Conjugates at World ADC San Diego
The 15th World ADC San Diego is designed to meet the needs of all ADC stakeholders, from those just entering the field to seasoned experts. The event promises a comprehensive experience with data-driven insights, case study presentations, and panel discussions led by pioneers in ADC development. Highlights include:
• 1,200+ Attendees: Connect with professionals from biotech, pharma, and academia to build strategic partnerships and explore new opportunities in the rapidly growing ADC space.
• 100+ Expert Speakers: Hear from industry leaders who will present the latest research, clinical results, and technological advancements driving the success of ADCs.
• Cutting-Edge Content: Sessions tailored to the full ADC lifecycle, covering linker-payload innovations, preclinical and clinical strategies, toxicity management, and commercial-scale manufacturing.
• Networking Opportunities: Engage with ADC leaders through more than 10 hours of networking sessions, including one-to-one meetings, interactive roundtables, and exhibition hall showcases.
Precision Antibody’s Role in Advancing ADCs
As a key player in the ADC space, Precision Antibody offers a suite of custom services designed to optimize the discovery and development of monoclonal antibodies, which are critical components of ADCs. With expertise spanning from antigen design to antibody production, the company is committed to accelerating ADC pipelines through:
• High-Affinity Antibody Discovery: Precision Antibody provides tailored solutions to discover high-affinity antibodies with the specificity needed for ADC success.
• Antibody Engineering & Optimization: Services such as humanization and affinity maturation enhance the therapeutic efficacy of ADCs while reducing off-target effects.
• End-to-End Support: Precision Antibody assists at every stage of ADC development, ensuring a seamless transition from early research to clinical application and beyond.
"Our goal is to empower ADC developers with the best possible antibody solutions," added Dr Hayashi. "By working closely with biopharma partners, we aim to accelerate their ADC programs and bring next-generation cancer treatments to patients faster."
Attendees are encouraged to visit Precision Antibody’s booth in the exhibition hall, where they will showcase their capabilities in antibody discovery and discuss how their services can support the development of cutting-edge ADC therapies.
Whether you're looking to refine your research strategy, overcome clinical hurdles, or scale up manufacturing, this conference provides the connections and knowledge necessary to take your ADC program to the next level. Explore how Precision Antibody can help you advance your ADC pipeline and be part of the future of cancer treatment. Join us at the 15th World ADC San Diego.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam